Dual Combination ART with Cabotegravir and Rilpivirine Is Effective for Maintaining HIV Virological Suppression.

Dual Combination ART with Cabotegravir and Rilpivirine Is Effective for Maintaining HIV Virological Suppression.

Watkins Richard R

Infectious Disease Alert

2015

2015-11

Results of the phase 2 LATTE study show that after 24 weeks of induction triple therapy, maintenance therapy with cabotegravir (a long-acting dolutegravir analogue) and rilpivirine led to virological suppression in 82% of patients, compared to 71 % who received efavirenz plus two NRTIs.

Adverse Drug Event; Anti-HIV Agents; Antiviral Agents – Therapeutic Use; Drug Combinations – Therapeutic Use

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

16–17

2

35